• Ownership

David N. Gill - Insider Trading & Ownership

Entity
Individual
Location
C/O Nxstage Medical Inc. (Nxtm), 439 South Union Street, 5 Th Floor, Lawrence, MA
Summary
The estimated net worth of David N. Gill is at least $518K dollars as of March 11, 2025. David N. Gill is the Director of Evolus, Inc. and owns shares of Evolus, Inc. (EOLS) stock worth about $448K. David N. Gill is the Director of Y-mAbs Therapeutics, Inc. and owns shares of Y-mAbs Therapeutics, Inc. (YMAB) stock worth about $69.9K.
All Insider Reports
All Insider Reports

Ownership of David N. Gill

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EOLS Evolus, Inc. Director $448K -$131K -22.6% Mar 7, 2025
YMAB Y-mAbs Therapeutics, Inc. Director $69.9K Jun 11, 2024
SBBP Strongbridge Biopharma plc Director Oct 5, 2021

Insider Transactions Reported by David N. Gill:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.